The Duke Human Vaccine Institute (DHVI) continues to lead cutting edge vaccine research against infectious diseases that impact global health. Basic science discoveries made using a variety of human and pathogen-derived proteins, designed, expressed and purified by a collaborative DHVI team have contributed to the identification of vaccine and therapeutic candidates currently being produced in Good Manufacturing Practice facilities for early phase clinical trials. A HIV-1 Envelope (Env) vaccine that elicits broadly neutralizing antibodies (bnAbs) has remained elusive, in part due to our limited understanding of the mechanisms of bnAb induction during natural infection. Dr. Williams has been awarded a NIH UM1 grant to develop new vaccine strategies that can induce more protective immune responses in the non-human primate (NHP) model by exploring innovative mRNA constructs for immunogen delivery that can elicit both protective and therapeutic B and T cell responses. Recently, Dr. Williams was also awarded a NIH U01 grant to develop new vaccine strategies that can induce antibodies in early-life capable of preventingHIV-1infection in pediatric populations. This computational immunobiology postdoctoral position is appropriate for a candidate who is enthusiastic and willing to undertake multiple molecular biology and computational approaches to evaluate host immunity elicited by candidate HIV vaccines when administered prophylactically, and/or HIV vaccines when administered therapeutically in combination with novel immunotherapies. The Williams lab has state-of-the-art equipment for single cell omics assays and support for computing power for data analyses. Here at DHVI, we value collaborations, and pride ourselves in providing an excellent environment for academic and professional growth.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree